DOE JGI early tester of 454’s benchtop sequencer on Y!Finance
454 Life Sciences, a Roche Company (SWX:RO) (SWX:ROG), announced today at the Association of Molecular Pathology Annual Meeting in Kissimmee, Florida a series of revolutionary developments which significantly expand the company’s high-throughput sequencing portfolio. Addressing the growing demand for next-generation sequencing data in everyday biological and clinical research, the company revealed the new GS Junior… [Read More]